Related Experiment Video
Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Cerebral Embolization During AF Ablation -Pathophysiology, Prevention and Management
Nasir Shariff1, Nagesh Antha2, Manish Roy2
1Department of Cardiovascular Medicine, Lehigh Valley Health Network. Pennsylvania. USA.
Catheter ablation for atrial fibrillation (AF) can lead to systemic embolization. This review covers event incidence, causes, risk factors, and strategies to prevent and treat these complications during AF ablation procedures.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Catheter ablation is a key treatment for symptomatic atrial fibrillation (AF).
- Instrumentation during AF ablation carries risks, including systemic embolization.
- Understanding these risks is crucial for patient safety.
Purpose of the Study:
- To review the incidence of systemic embolization during catheter ablation for atrial fibrillation.
- To explore the pathophysiologic mechanisms underlying these embolic events.
- To discuss risk factors, preventive measures, and treatment strategies.
Main Methods:
- Literature review of reported cases and studies on systemic embolization.
- Analysis of pathophysiologic explanations for embolic events.
- Synthesis of data on risk factors and clinical outcomes.
Main Results:
- Systemic embolization is a recognized complication of AF ablation.
- Various factors contribute to embolic event occurrence.
- Specific patient and procedural risk factors have been identified.
Conclusions:
- Awareness of embolization risks is vital for clinicians performing AF ablation.
- Proactive identification of risk factors can guide preventive strategies.
- Effective management protocols are necessary to mitigate complications.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism III: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

